GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 36563
Submission : 2021-12-29
Status : Active
Type : IV
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 28188
Submission : 2014-04-07
Status : Active
Type : IV
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 12715
Submission : 1997-10-20
Status : Inactive
Type : IV
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 12961
Submission : 1998-04-21
Status : Inactive
Type : IV
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 22790
Submission : 2009-05-20
Status : Inactive
Type : IV
FINISHED DOSAGE FORMULATIONS
DASABUVIR SODIUM; OMBITASVIR, PARITAPREVIR, RITONAVIR
Drug : VIEKIRA PAK (COPACKAGED)
Dosage Form : TABLET; ORAL
Application Number : 206619
Country : US
Patented : Yes
Drug : FENOFIBRATE
Dosage Form : TABLET; ORAL
Application Number : 217732
Country : US
Patented : No
Drug : APREPITANT
Dosage Form : CAPSULE; ORAL
Application Number : 207777
Country : US
Patented : No
Drug : CYCLOSPORINE
Dosage Form : CAPSULE; ORAL
Application Number : 65017
Country : US
Patented : No
EXCIPIENTS BY APPLICATIONS
MARKET PLACE
Reply
07 Feb 2025
Reply
04 Dec 2024
Reply
28 Aug 2024
Reply
07 Oct 2023
Reply
18 Jan 2020